Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

Continuous glucose monitors are small devices that automatically ... who don’t have diabetes, too. “Continuous glucose monitoring might be the best tool we have for precision nutrition ...

Senseonics (NYSE:SENS) is set to bring the longest-lasting continuous glucose monitor (CGM) to market following a major ...

The company, which manufactures CGM devices, partnered with Allison PR for a campaign that aimed to spread awareness of life ...

addressing one of the major drawbacks of existing CGM devices, deemed invasive due to the requirement of a needle inserted under the skin, which can cause discomfort. Additionally, a viscoelastic ...

CGM devices use a small filament inserted under ... familiar with how to access their patients’ CGM data and how to best interpret the data and standard reports, such as the Ambulatory Glucose ...

As previously announced, Trinity Biotech has entered into a non-binding Letter of Intent with Bayer for the launch of a CGM device in China and India. As part of this, Trinity Biotech is launching ...

And while another company could create a better CGM device, DexCom has proven incredibly ... just identified what they believe are the 10 best stocks for investors to buy now… and DexCom wasn ...

These devices are increasingly popular in diabetes management and health monitoring. As previously announced, Trinity Biotech has entered into a non-binding Letter of Intent with Bayer for the launch ...